D. Boral Capital Reiterates Buy Rating for CervoMed (NASDAQ:CRVO)
CervoMed (NASDAQ:CRVO – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at D. Boral Capital in a note issued to investors on Tuesday,Benzinga reports. They presently have a $10.00 price target on the stock. D. Boral Capital’s price target would indicate a potential upside of 62.07% from the stock’s current price. […]
CervoMed (NASDAQ:CRVO – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at D. Boral Capital in a note issued to investors on Tuesday,Benzinga reports. They presently have a $10.00 price target on the stock. D. Boral Capital’s price target would indicate a potential upside of 62.07% from the stock’s current price. […]
